Clinical trials
Phase 2 Non-Muscle Invasive Bladder Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 6 |
| Active, not recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anchiano Therapeutics Israel Ltd. | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Bristol-Myers Squibb | 1 |
| CG Oncology, Inc. | 1 |
| Janssen Research & Development, LLC | 1 |
| John Sfakianos | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Michael A. O'Donnell | 1 |
| Protara Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 20 |
| Urinary Bladder Neoplasms | 13 |
| Carcinoma in Situ | 5 |
| Carcinoma, Transitional Cell | 4 |
| Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.